Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
152 Avinguda de la Generalitat , Sant Cugat del Vallès, CT, 08174, ES
Grifols Partnership is a CDMO focused on added value injectable products, with a large international experience in the development and manufacturing of sterile drug products (small molecules) in glass vials and PP bags. Strict compliance with global manufacturing standards has earned us the highest accreditations, including authorizations by the U.S. FDA, EU and U.S. GMP and authorization for parametric release sterility.
The 72,300-square-foot facility was built on an investment of more than $160 million.
By: Patrick Lavery
$200M investment boosts sterile injectable drug production capacity in Albuquerque.
By: Charlie Sternberg
Certification supports commercial-scale production of QS-21 and other high-purity saponin fractions for human and veterinary vaccines.
The Oelde campus is expected to expand annual tablet production capacity to up to 10 billion tablets.
The 33,000-square-foot facility will support product development, hiring and the company’s next phase of growth.
New site will expand lipid-based drug delivery manufacturing capacity.
Dedicated suite at Gland Pharma’s Visakhapatnam facility will support Neuland’s growing sterile API customer demand.
New facility expands Artis BioSolutions’ end-to-end development and manufacturing platform.
The expansion increases commercial-scale batch tableting capacity for integrated supply of oral solid dosage products by 25%.
High Point facility can now support approved API manufacturing for the U.S., Japan and Australia.
New manufacturing facility to support pre-filled syringes, autoinjectors and future medicines.
The $45 million investment expands domestic sterile manufacturing capacity for pharma and biotech clients.
August Bioservices’ Ryan Downey discusses fill-finish capacity, Annex 1 readiness, technical expertise and the infrastructure needed to move injectable programs toward commercial launch.
Released By August Bioservices
The topping out ceremony marks a milestone in the Holly Springs facility’s development.
New facilities boost small-molecule API, HPAPI, and ADC payload manufacturing capacity.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
